Invention Grant
- Patent Title: Method of treating osteoarthritis with an antibody to NGF
-
Application No.: US16926232Application Date: 2020-07-10
-
Publication No.: US11518804B2Publication Date: 2022-12-06
- Inventor: Lynn MacDonald , Richard Torres , Marc R. Morra , Joel H. Martin , Joel C. Reinhardt , Paul Tiseo
- Applicant: REGENERON PHARMACEUTICALS, INC.
- Applicant Address: US NY Tarrytown
- Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee Address: US NY Tarrytown
- Agency: Bozicevic, Field & Francis LLP
- Agent Karl Bozicevic
- Main IPC: C07K16/22
- IPC: C07K16/22 ; A61K39/395 ; A61K45/06 ; A61K9/00 ; A61K39/00
Abstract:
Methods are disclosed for treating osteoarthritis in a human subject in need thereof, comprising administering to the subject a therapeutically effective amount of an anti-human NGF antibody, or antigen-binding fragment thereof, wherein at least one symptom associated with osteoarthritis is prevented, ameliorated or improved.
Public/Granted literature
- US20200339672A1 METHOD OF TREATING OSTEOARTHRITIS WITH AN ANTIBODY TO NGF Public/Granted day:2020-10-29
Information query
